About Monteris
Monteris Medical is a privately held company developing devices for minimally-invasive, MR-guided neurosurgery. Monteris markets the NeuroBlate® System for controlled, volumetric ablation of brain lesions. Monteris also offers the various Stereotactic anchoring devices for image-guided trajectory alignment, and the AtamA™ Stabilization System for MR based procedures requiring versatile head fixation. Now headquartered in Minneapolis, Minnesota, Monteris was founded in Winnipeg, Manitoba, and maintains a significant portion of its staff and operations there. For more information on Monteris Medical please visit www.monteris.com.
About MRI Interventions, Inc.

Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Building on the imaging power of MRI, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. The company's ClearPoint® system utilizes a hospital's existing diagnostic or intraoperative MRI scanner to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias. For more information, please visit www.mriinterventions.com.
SOURCE IMRIS Inc.
For further information:
For further IMRIS, Inc. information, please contact:
Kevin J. Berger, Marketing Communications Manager, IMRIS Inc., Tel: 763-203-6332, Email: kberger@imris.com;
For further Monteris information, please contact: Danielle Lewis, Lazar Partners Ltd., Tel: 212-843-0211, Email: dlewis@lazarpartners.com;
For further MRI Interventions, Inc. information, please contact: Frank Grillo, CEO, MRI Interventions, Inc., Tel: 949-900-6833, Email: fgrillo@mriinterventions.com
Back to HCB News